17 completed, 4 unknown, 3 recruiting. 24 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Completed 17, Unknown 4, Recruiting 3 |
| Phase 2 | 1 | Completed 1 |
Follow Immunoblastic Lymphadenopathy: new trials by email Literature Review of Immunoblastic Lymphadenopathy trials Research Report on Immunoblastic Lymphadenopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma PET-CTandct- DNAdetection, golidocitinib, Placebo - Maintenance Treatment of Peripheral T-cell Lymphoma | Phase 3 | Recruiting | Fudan University | 136 | 2026-03-27 | 2026-03-31 |
| A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype Duvelisib, Gemcitabine, Bendamustine - Lymphoma | Phase 3 | Recruiting | SecuraBio | 124 | 2025-05-19 | 2026-04-06 |
| Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma Soquelitinib, Belinostat, Pralatrexate - Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma | Phase 3 | Recruiting | Corvus Pharmaceuticals, Inc. | 150 | 2024-10-02 | 2026-09-25 |
| Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL Oral azacitidine, Romidepsin, Bendamustine - Relapsed Angioimmunoblastic T-Cell Lymphoma, Refractory Angioimmunoblastic T-cell Lymphoma | Phase 3 | Completed | The Lymphoma Academic Research Organisation | 86 | 2018-11-09 | 2026-04-23 |
| Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer | Phase 3 | Unknown | University of Glasgow | 214 | 2009-04-01 | 2011-05-13 |
| American Ginseng in Treating Patients With Fatigue Caused by Cancer American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 364 | 2008-10-01 | 2017-02-09 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Case Comprehensive Cancer Center | 583 | 2008-04-01 | 2020-07-27 |
| Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP alemtuzumab, chemotherapy - Peripheral T Cell Lymphoma, Unspecified, Angioimmunoblastic Lymphadenopathy | Phase 3 | Unknown | University of Göttingen | 274 | 2008-02-01 | 2012-05-07 |
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia amoxicillin-clavulanate potassium, ciprofloxacin, psychosocial assessment and care - Brain and Central Nervous System Tumors, Lymphoma | Phase 3 | Unknown | Clatterbridge Centre for Oncology | 400 | 2007-07-01 | 2013-08-12 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose - Anemia, Leukemia | Phase 3 | Completed | Mayo Clinic | 502 | 2006-01-01 | 2011-05-17 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Vanderbilt-Ingram Cancer Center | 98 | 2005-05-01 | 2012-09-06 |
| Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma rituximab, cisplatin, cytarabine - Lymphoma | Phase 3 | Completed | NCIC Clinical Trials Group | 849 | 2003-08-27 | 2023-08-23 |
| Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer darbepoetin alfa, epoetin alfa - Anemia, Leukemia | Phase 3 | Completed | Jonsson Comprehensive Cancer Center | 14 | 2003-08-01 | 2020-08-03 |
| Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia cefepime hydrochloride, levofloxacin - Fever, Sweats, and Hot Flashes, Infection | Phase 3 | Unknown | Jonsson Comprehensive Cancer Center | 2001-09-01 | 2013-12-19 | |
| Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma filgrastim, rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | German High-Grade Non-Hodgkin's Lymphoma Study Group | 1506 | 2001-01-01 | 2021-05-18 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 100 | 2000-10-01 | 2016-07-06 |
| Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment caspofungin acetate, liposomal amphotericin B - Cancer | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 2000-08-01 | 2013-01-18 | |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Fragmin, placebo - Cervical Cancer, Chronic Myeloproliferative Disorders | Phase 3 | Completed | Jonsson Comprehensive Cancer Center | 2000-04-01 | 2020-08-03 | |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer St. John's wort - Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 1999-12-01 | 2013-01-18 |
Showing 20 of 24. Sign in to see all of them.
Lymphoma, Large-Cell, Anaplastic (20) · Lymphoma, Large B-Cell, Diffuse (19) · Burkitt Lymphoma (18) · Lymphoma, Follicular (18) · Lymphoma, Mantle-Cell (18) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (18) · Leukemia, Lymphocytic, Chronic, B-Cell (17) · Lymphoma, B-Cell, Marginal Zone (17) · Lymphoma, Large-Cell, Immunoblastic (17) · Lymphoma, Non-Hodgkin (17) · Lymphoma, T-Cell, Cutaneous (17) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (17) · Hodgkin Disease (16) · Lymphoma (16)
Hemic and Lymphatic Diseases (24) · Immune System Diseases (24) · Immunoproliferative Disorders (24) · Lymphadenopathy (24) · Lymphatic Diseases (24) · Neoplasms by Histologic Type (23) · Lymphoma, T-Cell (21) · Lymphoma, B-Cell (19) · Lymphoproliferative Disorders (19) · DNA Virus Infections (18) · Disease Attributes (18) · Epstein-Barr Virus Infections (18) · Hematologic Diseases (18) · Herpesviridae Infections (18) · Leukemia, Lymphoid (18)
Gemcitabine (3) · Bendamustine Hydrochloride (2) · Cyclophosphamide (2) · Darbepoetin alfa (2) · Doxorubicin (2) · Early Intervention, Educational (2) · Levofloxacin (2) · Rituximab (2) · liposomal amphotericin B (2) · 10-propargyl-10-deazaaminopterin (1) · Alemtuzumab (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Antilymphocyte Serum (1) · Asian ginseng (1) · Azacitidine (1)
Jonsson Comprehensive Cancer Center (3) · Alliance for Clinical Trials in Oncology (2) · Memorial Sloan Kettering Cancer Center (2) · NCIC Clinical Trials Group (2) · Cancer Research Campaign Clinical Trials Centre (1) · Case Comprehensive Cancer Center (1) · Clatterbridge Centre for Oncology (1) · Corvus Pharmaceuticals, Inc. (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Fudan University (1) · German High-Grade Non-Hodgkin's Lymphoma Study Group (1) · INSYS Therapeutics Inc (1) · Mayo Clinic (1) · Roswell Park Cancer Institute (1) · SecuraBio (1)
United States (14) · United Kingdom (5) · Germany (4) · Belgium (3) · Canada (3) · France (3) · Australia (2) · Czechia (2) · Denmark (2) · Italy (2) · Netherlands (2) · Spain (2) · Austria (1) · China (1) · Greece (1)
John A. Glaspy, MD, MPH (2) · Barry J.A. Laird, MD (1) · Charles L. Loprinzi, MD (1) · David J. Straus, MD (1) · Debra Barton, RN, PhD, AOCN, FAAN (1) · Eduardo Bruera, MD (1) · Ernest Marshall, MD (1) · Kent Sepkowitz, MD (1) · Larry Dillaha, MD (1) · Marie T. Fallon (1) · Mary C. Territo, MD (1)
PMID 15459300, PMID 16148284, PMID 16710026, PMID 17397698, PMID 18226581, PMID 22337718, PMID 22480131, PMID 23335369, PMID 24493716, PMID 25113753, PMID 25135997, PMID 25267740, PMID 25403207, PMID 25482745, PMID 26109202, PMID 26700120, PMID 26700123, PMID 27020837, PMID 27993811, PMID 28398499, PMID 28516671, PMID 29072976, PMID 29097500, PMID 30694529, PMID 31123029, PMID 32396614, PMID 36999619, PMID 38796193, PMID 39227453, PMID 40503814
P30CA015083 (1), P30CA068485 (1), R01CA127655 (1)